Onco Therapies Limited, a wholly owned subsidiary of Strides Arcolab Limited (Strides) has received ANDA approval for Ifosfamide Injection 50 mg/ mL packaged in 1 gram/ 20 mL and 3 grams/ 60 mL Single-dose vials.
According to IMS data, the US market for generic Ifosfamide is approximately $ 15 million.
Ifosfamide is part of the oncology portfolio licensed to Pfizer for the US market and the product is available for immediate launch. Ifosfamide is a chemotherapy drug that is usually used to treat sarcoma, testicular cancer and some types of lymphomas. Occasionally, it may be used to treat other types of cancer.
EP News Bureau